Clinical Trial 40196

share

Garden Grove, CA 92845


Study Summary:

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to
Evaluate the Efficacy and Safety of Pimavanserin as Adjunctive Treatment
for the Negative Symptoms of Schizophrenia


Qualified Participants Must:

• Male or female,between 18 and 55 years of age at the time of Screening


Qualified Participants May Receive:

Compensation for time and gas 


Research Site Profile

View Clinic Profile


Study is Available At:

CNS Network
12772 Valley View Ave, Suite 3
Garden Grove, CA 92845
View Clinic Location

 


If you or someone you care for is interested in participating in this clinical trial and lives within 50 miles of the clinic, please complete the form below and click 'I Am Interested In This Study'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.